Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Recruiting
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT01788592
- Lead Sponsor
- Seung-Jung Park
- Brief Summary
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50000
Inclusion Criteria
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
Exclusion Criteria
- patients with a mixture of several drug eluting stents
- terminal illness with life expectancy less than 1 year
- patients with cardiogenic shock
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major Adverse Cardiac Event 1year Death from any causes, myocardial infarction or any repeat revascularization
- Secondary Outcome Measures
Name Time Method The composite of Death or myocardial infarction 1year Stent thrombosis by Academic Research Consortium criteria 1year Myocardial Infarction 1year Target vessel revascularization 1year all cause Death 1year New lesion revascularization 1year Target lesion revascularization 1year Any repeat revascularization 1year
Trial Locations
- Locations (1)
Asan Medical Center
🇰🇷Seoul, Korea, Republic of